VTVT vs. VEIPX
Compare and contrast key facts about vTv Therapeutics Inc. (VTVT) and Vanguard Equity Income Fund Investor Shares (VEIPX).
VEIPX is managed by Vanguard. It was launched on Mar 21, 1988.
Performance
VTVT vs. VEIPX - Performance Comparison
Loading graphics...
VTVT vs. VEIPX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VTVT vTv Therapeutics Inc. | 1.35% | 189.60% | 20.08% | -56.62% | -33.39% | -46.51% | 9.41% | -35.85% | -55.91% | 24.43% |
VEIPX Vanguard Equity Income Fund Investor Shares | 1.48% | 17.14% | 14.80% | 7.66% | -0.16% | 25.41% | 2.97% | 25.21% | -5.75% | 17.60% |
Returns By Period
In the year-to-date period, VTVT achieves a 1.35% return, which is significantly lower than VEIPX's 1.48% return. Over the past 10 years, VTVT has underperformed VEIPX with an annualized return of -15.09%, while VEIPX has yielded a comparatively higher 11.24% annualized return.
VTVT
- 1D
- 2.19%
- 1M
- 13.85%
- YTD
- 1.35%
- 6M
- 68.88%
- 1Y
- 147.13%
- 3Y*
- 7.85%
- 5Y*
- -18.91%
- 10Y*
- -15.09%
VEIPX
- 1D
- 1.64%
- 1M
- -4.28%
- YTD
- 1.48%
- 6M
- 4.75%
- 1Y
- 15.97%
- 3Y*
- 14.51%
- 5Y*
- 10.69%
- 10Y*
- 11.24%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VTVT vs. VEIPX — Risk / Return Rank
VTVT
VEIPX
VTVT vs. VEIPX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for vTv Therapeutics Inc. (VTVT) and Vanguard Equity Income Fund Investor Shares (VEIPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| VTVT | VEIPX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.97 | 1.05 | +0.91 |
Sortino ratioReturn per unit of downside risk | 2.48 | 1.53 | +0.95 |
Omega ratioGain probability vs. loss probability | 1.31 | 1.23 | +0.08 |
Calmar ratioReturn relative to maximum drawdown | 3.39 | 1.53 | +1.86 |
Martin ratioReturn relative to average drawdown | 6.81 | 6.72 | +0.09 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| VTVT | VEIPX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.97 | 1.05 | +0.91 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.20 | 0.77 | -0.97 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.13 | 0.69 | -0.82 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.17 | 0.64 | -0.81 |
Correlation
The correlation between VTVT and VEIPX is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
VTVT vs. VEIPX - Dividend Comparison
VTVT has not paid dividends to shareholders, while VEIPX's dividend yield for the trailing twelve months is around 10.84%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VTVT vTv Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VEIPX Vanguard Equity Income Fund Investor Shares | 10.84% | 10.94% | 9.74% | 7.87% | 8.69% | 7.62% | 2.77% | 4.36% | 10.87% | 2.98% | 3.78% | 6.39% |
Drawdowns
VTVT vs. VEIPX - Drawdown Comparison
The maximum VTVT drawdown since its inception was -98.19%, which is greater than VEIPX's maximum drawdown of -54.12%. Use the drawdown chart below to compare losses from any high point for VTVT and VEIPX.
Loading graphics...
Drawdown Indicators
| VTVT | VEIPX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.19% | -54.12% | -44.07% |
Max Drawdown (1Y)Largest decline over 1 year | -39.58% | -10.97% | -28.61% |
Max Drawdown (5Y)Largest decline over 5 years | -94.27% | -15.16% | -79.11% |
Max Drawdown (10Y)Largest decline over 10 years | -97.48% | -35.26% | -62.22% |
Current DrawdownCurrent decline from peak | -90.70% | -5.33% | -85.37% |
Average DrawdownAverage peak-to-trough decline | -77.61% | -5.52% | -72.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.68% | 2.49% | +17.19% |
Volatility
VTVT vs. VEIPX - Volatility Comparison
vTv Therapeutics Inc. (VTVT) has a higher volatility of 21.27% compared to Vanguard Equity Income Fund Investor Shares (VEIPX) at 3.68%. This indicates that VTVT's price experiences larger fluctuations and is considered to be riskier than VEIPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| VTVT | VEIPX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.27% | 3.68% | +17.59% |
Volatility (6M)Calculated over the trailing 6-month period | 58.21% | 7.86% | +50.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.53% | 15.05% | +60.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.82% | 13.92% | +82.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 120.07% | 16.30% | +103.77% |